Robinson Helicopter Collaborates with Unither Bioelectrics on Hydrogen-Powered Helicopters
Key Ideas
- Robinson Helicopter and Unither Bioelectrics signed an agreement to develop hydrogen-powered helicopters based on R44 and R66 platforms.
- The collaboration aims to obtain certifications from Transport Canada Civil Aviation and Federal Aviation Administration for zero-emission helicopters.
- UB plans to use the hydrogen-powered helicopters for urgent organ-delivery services, focusing on sustainable transportation solutions for life-saving organs.
- UB also plans to develop a fleet of electric- and hydrogen-powered aircraft for human transplant organ delivery, emphasizing zero-operational carbon emissions.
Robinson Helicopter Company recently announced a collaboration with Canadian company Unither Bioelectrics to develop hydrogen-powered helicopters. The agreement involves utilizing Robinson's engineering, technical, and regulatory expertise to streamline the development and certification process of zero-emission helicopters based on the R44 and R66 platforms. The goal is to achieve certifications from Transport Canada Civil Aviation and Federal Aviation Administration for these hydrogen-electric helicopters. David Smith, the President and CEO of Robinson Helicopter, expressed the company's commitment to advancing the vertical lift industry by partnering with Unither Bioelectronics to hasten the arrival of zero-emission helicopters. Additionally, Unither Bioelectrics, upon certification, plans to employ these hydrogen-powered helicopters for urgent organ-delivery services, focusing on sustainable transportation solutions for life-saving organs. Mikael Cardinal, the Vice President of Program Management and Organ Delivery Systems at UB, highlighted the significance of hydrogen-powered aircraft in sustainable aviation and emphasized the commitment to developing a fleet with zero-operational carbon emissions. UB aims to operate a fleet of electric- and hydrogen-powered aircraft, crewed and uncrewed, capable of vertical take-off and landing at hospitals for swift delivery of manufactured organs intended for human transplant.